Fraction 1 capsular antigen (F1) purification from Yersinia pestis CO92 and from an Escherichia coli recombinant strain and efficacy against lethal plague challenge
about
Plague Vaccine Development: Current Research and Future TrendsPrinciples of antidote pharmacology: an update on prophylaxis, post-exposure treatment recommendations and research initiatives for biological agentsTranscriptional regulation of opaR, qrr2-4 and aphA by the master quorum-sensing regulator OpaR in Vibrio parahaemolyticusMolecular characterization of direct target genes and cis-acting consensus recognized by quorum-sensing regulator AphA in Vibrio parahaemolyticusMutated and bacteriophage T4 nanoparticle arrayed F1-V immunogens from Yersinia pestis as next generation plague vaccinesYersinia pestis--etiologic agent of plagueBroad T cell immunity to the LcrV virulence protein is induced by targeted delivery to DEC-205/CD205-positive mouse dendritic cells.Immune defense against pneumonic plaguePurification and protective efficacy of monomeric and modified Yersinia pestis capsular F1-V antigen fusion proteins for vaccination against plague.Identification and characterization of a neutralizing monoclonal antibody that provides complete protection against Yersinia pestis.The smpB-ssrA mutant of Yersinia pestis functions as a live attenuated vaccine to protect mice against pulmonary plague infectionHuman immune response to a plague vaccine comprising recombinant F1 and V antigens.LcrV plague vaccine with altered immunomodulatory propertiesProtective efficacy of recombinant Yersinia outer proteins against bubonic plague caused by encapsulated and nonencapsulated Yersinia pestisImmune response to Yersinia outer proteins and other Yersinia pestis antigens after experimental plague infection in mice.Biosafety level 2 model of pneumonic plague and protection studies with F1 and Psa.Protective immunity against a lethal respiratory Yersinia pestis challenge induced by V antigen or the F1 capsular antigen incorporated into adenovirus capsid.Establishment of a Swiss Webster mouse model of pneumonic plague to meet essential data elements under the animal rule.Protection conferred by recombinant Yersinia pestis antigens produced by a rapid and highly scalable plant expression system.Vulnerabilities in Yersinia pestis caf operon are unveiled by a Salmonella vectorLcrV delivered via type III secretion system of live attenuated Yersinia pseudotuberculosis enhances immunogenicity against pneumonic plague.Flagellin is an effective adjuvant for immunization against lethal respiratory challenge with Yersinia pestis.Primary pneumonic plague in the African Green monkey as a model for treatment efficacy evaluation.Effective protective immunity to Yersinia pestis infection conferred by DNA vaccine coding for derivatives of the F1 capsular antigen.Administration of antibody to the lung protects mice against pneumonic plague.H-NS is a repressor of major virulence gene loci in Vibrio parahaemolyticus.Plague in Guinea pigs and its prevention by subunit vaccinesCell density- and quorum sensing-dependent expression of type VI secretion system 2 in Vibrio parahaemolyticus.Development of a vaccinia virus based reservoir-targeted vaccine against Yersinia pestisAdvanced Development of the rF1V and rBV A/B Vaccines: Progress and Challenges.Recombinant V antigen protects mice against pneumonic and bubonic plague caused by F1-capsule-positive and -negative strains of Yersinia pestis.Effect of Yersinia pestis YopM on experimental plague.Expression of the Yersinia pestis capsular antigen (F1 antigen) on the surface of an aroA mutant of Salmonella typhimurium induces high levels of protection against plague.Regions of Yersinia pestis V antigen that contribute to protection against plague identified by passive and active immunization.Intraspecific diversity of Yersinia pestis.Development of in vitro correlate assays of immunity to infection with Yersinia pestis.Beyond Helper Phage: Using "Helper Cells" to Select Peptide Affinity Ligands.A comparison of immunogenicity and protective immunity against experimental plague by intranasal and/or combined with oral immunization of mice with attenuated Salmonella serovar Typhimurium expressing secreted Yersinia pestis F1 and V antigen.Conjugation of Y. pestis F1-antigen to gold nanoparticles improves immunogenicity.Interaction between Yersinia pestis and the host immune system
P2860
Q28066875-972BE6A5-E2CB-401D-92CD-F72E44246993Q28384852-765CEC8E-EB0C-4AB7-A79D-5C6F42E3F044Q28482223-E2B8D1C6-218B-48C5-B5F5-A84C77CFF715Q28483699-952E4C6B-FF0E-445B-B691-B49562C3F6EAQ28678943-F8F8D78E-E187-40AF-8B8B-82CC486CB9C6Q29619320-C632301E-27F6-4D28-A52D-FDC16F385845Q33310431-599E6DB6-0834-492E-A8D3-511F8C65AD3AQ33584403-A6F778C2-D795-40E6-BD08-860403BC9ABBQ33612949-DAF1A958-F2AD-4333-9321-AAC27E8DBB2BQ33653050-C45CB38E-76A3-4D2C-A132-826026740444Q33675834-AA0A1AE8-576A-44E2-A94F-5071A4B4703EQ33788286-E6CD765E-3FF3-45CE-B85E-AF3C54E34992Q33946882-B6800C52-945D-4410-8C73-1693619AE8CFQ34000759-EC133DAF-D352-4937-933C-E25EED7468E1Q34000948-C216E3F9-1801-41A9-A942-873D3E59AD70Q34045080-B9F31EFD-F18C-4CB9-BE4A-2E920C99FE71Q34123275-0944C0EE-6497-4068-9557-0CE580E7C1C6Q34159659-B24D4BCE-2BEE-4A0B-B14B-2EC613B53D21Q34250117-356FC52D-7599-4FC5-A1C7-F3F6EB492D6BQ34257405-D28FD225-AA11-4573-970E-F88CF456B722Q34298699-664DF668-3871-44B1-BBEE-42773E6A5E81Q34334406-E29990D8-D8A3-46DF-8614-1ADAA92062D9Q34348619-74EB65FE-D11F-4C30-BC28-9EC3D374F367Q34532258-AE2D71D1-FD62-4A00-B665-52287E5A74FCQ34601788-34B6D0D9-E66B-4FBC-9E6C-4B5243C45C70Q34687161-EA92FF4E-F658-4AA9-83F9-CF1ABC6C286BQ34805666-FA9EEA11-9304-4FC0-8960-5223328962ACQ34974216-5AE225AA-77F1-473E-AD2B-7480E59EEC3CQ35090599-04E83A03-145B-4122-9235-14C15E3EE631Q35418294-DEE3D6CE-BE2F-417C-AC00-7A3052087B96Q35528592-3B899634-EAA3-42FF-962A-07A58C2F567FQ35544027-718BE4D7-F47E-4AEB-8A29-E7B2EA1E563EQ35547366-52C1FE94-5E24-4D8C-958E-684C3D18B33BQ35557573-6EDAE5D9-9D2D-482C-8A33-E995C0DB740DQ35745842-F9B6C773-D6D6-46E0-B289-3EF14E583F32Q35783560-E6689CE5-E879-430E-8F4A-6DD73A6BB221Q36132303-58DB382F-FCD5-47E7-908A-C1E41F49CA12Q36237899-FAF9EABD-0664-4D03-845B-0B36DCD51A77Q36368527-7162481D-C28A-400F-9DFD-0229E2A16731Q36594020-E02253C8-1B45-46BE-9011-D6D6951B8C48
P2860
Fraction 1 capsular antigen (F1) purification from Yersinia pestis CO92 and from an Escherichia coli recombinant strain and efficacy against lethal plague challenge
description
1996 nî lūn-bûn
@nan
1996 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
Fraction 1 capsular antigen (F ...... gainst lethal plague challenge
@ast
Fraction 1 capsular antigen (F ...... gainst lethal plague challenge
@en
type
label
Fraction 1 capsular antigen (F ...... gainst lethal plague challenge
@ast
Fraction 1 capsular antigen (F ...... gainst lethal plague challenge
@en
prefLabel
Fraction 1 capsular antigen (F ...... gainst lethal plague challenge
@ast
Fraction 1 capsular antigen (F ...... gainst lethal plague challenge
@en
P2093
P2860
P1476
Fraction 1 capsular antigen (F ...... gainst lethal plague challenge
@en
P2093
Anderson GW Jr
Andrews GP
Friedlander AM
P2860
P304
P407
P577
1996-06-01T00:00:00Z